Profile
Dr. Brennan was previously a General Partner at Oxford Bioscience Partners.
Prior to that, he was President and Chief Executive Officer of Gene Logic (NASDAQ: GLGC).
During Dr. Brennan’s time at Gene Logic, he built the company from a start-up to a public company that achieved a market capitalization of over $5 billion.
He raised three rounds of venture capital and led Gene Logic to an IPO in November, 1997 and a large secondary public offering in January, 2000.
Dr. Brennan’s previous experience includes six years in the biopharmaceutical industry, where he has served as Vice President, Business Development for Boehringer Mannheim Therapeutics.
Dr. Brennan received a B.S.
in Biochemistry, a Ph.D.
in neurobiology and a M.D.
from the University of Witwatersrand, Johannesburg, South Africa.
John Barnard active positions
| Companies | Position | Start |
|---|---|---|
Pearl Street Venture Funds
Pearl Street Venture Funds Investment ManagersFinance Pearl Street Ventures Funds invests in companies located in United States, primarily in Indiana. The firm targets companies operating across a broad range of sectors. It provide financing for early stage capital requirements. | Chief Investment Officer | - |
Barnard Associates, Inc.
Barnard Associates, Inc. Investment ManagersFinance Barnard Associates invests in companies located in the United States. The firm focuses on broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Founder | 2009-08-13 |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceuticals products | Director/Board Member | - |
Flowco, Inc.
Flowco, Inc. Medical SpecialtiesHealth Technology Develops biomedical devices for diagnostics | Director/Board Member | 2010-08-15 |
YourEncore, Inc.
YourEncore, Inc. Internet Software/ServicesTechnology Services Provides business support services | Founder | 2002-12-31 |
Barnard Life Sciences LLC | Founder | 2000-12-31 |
AIT Bioscience LLC
AIT Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Operates as bioanalytical laboratory for immunoassay testing | Director/Board Member | - |
Former positions of John Barnard
| Companies | Position | End |
|---|---|---|
NNC Group LLC
NNC Group LLC Miscellaneous Commercial ServicesCommercial Services Provides product promotion and product support solutions | Director/Board Member | 2008-11-02 |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Private Equity Investor | 2002-12-31 |
| ░░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░ ░░░░░ ░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of John Barnard
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners (OBP) focuses on investments in emerging, entrepreneurial-driven companies in the life sciences and healthcare sectors. They look for companies in the medical devices, R&D instruments and systems and therapeutics industries and for companies with breakthrough life sciences technology. The firm also invests in non-life science based technologies that have novel healthcare applications. OBP considers investments at almost any stage, but they place emphasis on early-stage opportunities. Investments range from $1 million to $10 million, but they may also make smaller seed investments in certain situations. OBP acts as the lead investor to organize an appropriate syndicate of co-investors. They consider investments in almost all geographic locations. | Finance |
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Develops and discovers pharmaceutical | Health Technology |
YourEncore, Inc.
YourEncore, Inc. Internet Software/ServicesTechnology Services Provides business support services | Technology Services |
CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Flowco, Inc.
Flowco, Inc. Medical SpecialtiesHealth Technology Develops biomedical devices for diagnostics | Health Technology |
AIT Bioscience LLC
AIT Bioscience LLC Miscellaneous Commercial ServicesCommercial Services Operates as bioanalytical laboratory for immunoassay testing | Commercial Services |
Butler University
Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hanover College
Hanover College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NNC Group LLC
NNC Group LLC Miscellaneous Commercial ServicesCommercial Services Provides product promotion and product support solutions | Commercial Services |
University of the Witwatersrand
University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pearl Street Venture Funds
Pearl Street Venture Funds Investment ManagersFinance Pearl Street Ventures Funds invests in companies located in United States, primarily in Indiana. The firm targets companies operating across a broad range of sectors. It provide financing for early stage capital requirements. | Finance |
Barnard Life Sciences LLC | |
Barnard Associates, Inc.
Barnard Associates, Inc. Investment ManagersFinance Barnard Associates invests in companies located in the United States. The firm focuses on broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceuticals products | Health Technology |
- Stock Market
- Insiders
- John Barnard
















